Remove 2030 Remove Generic Medicine Remove Pharmaceutical Companies
article thumbnail

Navigating tariffs and diplomacy: the future of India-US pharmaceutical trade

Pharmaceutical Technology

Leyla Hasanzadeh June 18, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Tech transfer for manufacturing purposes in India will be difficult if Trump imposes import duties on pharmaceuticals. The goal is to take annual bilateral trade between the two nations to $500 billion by 2030 from the current $190 billion.